
-
2010
Company Description
Cormorant Pharmaceuticals is a biopharmaceutical company.
Cormorant Pharmaceuticals is a privately held, biopharmaceutical company founded by Maarten de Château and Urban Paulsson. The company is based at the Karolinska Institute Science Park in Stockholm, Sweden. Based on mounting research pointing to IL-8 being an important driver of malignant tumors, HuMax-IL8 was acquired from Genmab A/S and taken into development by Cormorant. HuMax-IL8, is a fully human monoclonal antibody
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Company Website:
-
Company E-mail:
-
Company Address:
Karolinska Institute Science Park Fogdevreten 2ASolnaSweden -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits